• Baird Medical Investment Holdings filed an audited restatement of its annual results for the year ended Dec. 31, 2025.
• Net loss was USD 27.54 million, versus net income of USD 12.6 million a year earlier; revenue fell to USD 22.54 million from USD 37.04 million.
• Operating loss was USD 25.63 million, versus operating income of USD 15.32 million; operating expenses rose to USD 44.51 million from USD 17.34 million.
• Cash was USD 178,321, restricted cash was USD 387,496; short-term bank loans were USD 10.43 million at year-end.
• Accounts receivable, net was USD 42.53 million; allowance for expected credit losses was USD 4.76 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-087081), on July 27, 2026, and is solely responsible for the information contained therein.